A phase II study of eribulin in patients with HER2-negative, metastatic breast cancer: Evaluation of efficacy, toxicity, and patient-reported outcomes.

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Patient Reported

P1-12-02: Patient-Reported Outcomes (PROs) from a Randomized Phase II Study (TDM4450g/BO21976) of Trastuzumab Emtansine (T-DM1) vs Trastuzumab Plus Docetaxel (HT) in Previously Untreated HER2−Positive Metastatic Breast Cancer (MBC).

10.1158/0008-5472.sabcs11-p1-12-02 ◽

2011 ◽

Cited By ~ 2

Author(s):

GV Bianchi ◽

J Kocsis ◽

L Dirix ◽

Y Torigoe ◽

D Lalla ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Randomized Phase Ii ◽

Patient Reported

Abstract P2-15-04: Patient-reported outcomes in a randomized, optimal dose finding, phase II study of triweekly nab-paclitaxel in patients with metastatic breast cancer (the ABROAD study)

10.1158/1538-7445.sabcs19-p2-15-04 ◽

2020 ◽

Author(s):

Hiroaki Kato ◽

Fumikata Hara ◽

Masahiro Kitada ◽

Masato Takahashi ◽

Yuichiro Kikawa Yuichiro Kikawa ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Optimal Dose ◽

Dose Finding ◽

Patient Reported

A phase II, multicenter, single-arm trial of eribulin as first or second line chemotherapy for HER2-negative advanced or metastatic breast cancer: Evaluation of efficacy, safety, and patient-reported outcomes.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e13059 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e13059-e13059 ◽

Cited By ~ 2

Author(s):

Mitsuhiko Iwamoto ◽

Kosei Kimura ◽

Satoru Tanaka ◽

Daigo Yamamoto ◽

Katsuhide Yoshidome ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Second Line ◽

Second Line Chemotherapy ◽

Patient Reported ◽

Line Chemotherapy

A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-018-3567-y ◽

2018 ◽

Vol 81 (5) ◽

pp. 923-933

Author(s):

Kosei Kimura ◽

Mitsuhiko Iwamoto ◽

Satoru Tanaka ◽

Daigo Yamamoto ◽

Katsuhide Yoshidome ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Metastatic Breast ◽

Second Line ◽

Second Line Chemotherapy ◽

Patient Reported ◽

Line Chemotherapy

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Her2 Positive

Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3414442 ◽

2019 ◽

Author(s):

Yeon Hee Park ◽

Tae-Yong Kim ◽

Gun Min Kim ◽

Kyung Hae Jung ◽

Seok Yun Kang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Gnrh Agonist ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Premenopausal Women ◽

Hormone Receptor Positive

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.2018-0243 ◽

2018 ◽

Vol 24 (6) ◽

pp. 743 ◽

Cited By ~ 1

Author(s):

Elisabetta Pietri ◽

Ilaria Massa ◽

Sara Bravaccini ◽

Sara Ravaioli ◽

Maria Maddalena Tumedei ◽

...

Keyword(s):

Breast Cancer ◽

Androgen Receptor ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast

Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.041 ◽

2010 ◽

Vol 10 (4) ◽

pp. 313-317 ◽

Cited By ~ 3

Author(s):

Juan de la Haba-Rodriguez ◽

Rosario González Mancha ◽

Gumersindo Pérez Manga ◽

Enrique Aranda Aguilar ◽

José Manuel Baena Cañada ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-005-0675-y ◽

2005 ◽

Vol 131 (9) ◽

pp. 568-574 ◽

Cited By ~ 8

Author(s):

Peter Schmid ◽

Volker Heilmann ◽

Carsten-Oliver Schulz ◽

Annette Dieing ◽

Silvia Lehenbauer-Dehm ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Prolonged Infusion

Phase II study of gemcitabine plus cisplatin in metastatic breast cancer

Anti-Cancer Drugs ◽

10.1097/00001813-200606000-00011 ◽

2006 ◽

Vol 17 (5) ◽

pp. 565-570 ◽

Cited By ~ 15

Author(s):

Homero Fuentes ◽

German Calderillo ◽

Francisco Alexander ◽

Marcelino Ramirez ◽

Enrique Avila ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast